Earnings Feed
Start Free
Home/Insiders/Holtzman Steven H
HS
SEC Insider//CIK 0001300247

Holtzman Steven H

CIK 00013002474 companiesCAMBRIDGE, MA
SEC Profile

Transactions

50

Companies

4

Filings

8

CIK

0001300247

Recent Transactions

50 trades
  • Award
    Camp4 Therapeutics Corp$CAMP

    Stock Option (Right to Buy)

    2025-06-25+9,000→ 9,000 total
  • Conversion
    Camp4 Therapeutics Corp$CAMP

    Common Stock

    2024-10-15+8,917→ 108,946 total
  • Conversion
    Camp4 Therapeutics Corp$CAMP

    Series A Prime Preferred Stock

    2024-10-15−100,014→ 0 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2016-02-23−579→ 4,611 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2016-02-23+579→ 8,599 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2016-02-23$258.99/sh−273→ 8,326 total
  • Other
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2016-02-23−1,149→ 3,462 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2016-02-12+2,142→ 8,839 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2016-02-12+1,052→ 7,192 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2016-02-12−1,052→ 3,842 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2016-02-12−2,142→ 2,147 total
  • Other
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2016-02-12−1,394→ 2,448 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2016-02-12$247.22/sh−495→ 6,697 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2016-02-12$247.22/sh−819→ 8,020 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2016-02-08−2,709→ 0 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2016-02-08+2,709→ 7,030 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2016-02-08$250.77/sh−890→ 6,140 total
  • Award
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2015-02-23+5,190→ 5,190 total
  • Sale
    BIOGEN INC.$BIIB

    Common Stock

    2015-02-17$389.11/sh−2,128→ 4,321 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2015-02-12$392.11/sh−1,009→ 5,660 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2015-02-12$392.11/sh−703→ 6,449 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2015-02-12+1,492→ 7,152 total
  • Other
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2015-02-12−954→ 4,894 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2015-02-12−2,142→ 4,289 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2015-02-12+2,142→ 6,669 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2015-02-12−1,492→ 5,848 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2015-02-08$402.00/sh−1,275→ 4,527 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2015-02-08+2,705→ 5,802 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2015-02-08−2,705→ 2,709 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2015-02-01−5,157→ 0 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2015-02-01$389.16/sh−2,060→ 3,097 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2015-02-01+5,157→ 5,157 total
  • Sale
    BIOGEN INC.$BIIB

    Common Stock

    2014-12-02$335.65/sh−1,749→ 0 total
  • Sale
    BIOGEN INC.$BIIB

    Common Stock

    2014-11-11$330.00/sh−1,750→ 1,749 total
  • Sale
    BIOGEN INC.$BIIB

    Common Stock

    2014-10-01$330.97/sh−1,750→ 3,499 total
  • Gift
    BIOGEN INC.$BIIB

    Common Stock

    2014-09-18−500→ 5,249 total
  • Sale
    BIOGEN INC.$BIIB

    Common Stock

    2014-03-17$334.83/sh−1,221→ 8,191 total
  • Sale
    BIOGEN INC.$BIIB

    Common Stock

    2014-02-18$327.90/sh−1,222→ 9,412 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2014-02-12$323.04/sh−1,010→ 10,634 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2014-02-12+2,142→ 11,644 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2014-02-12−2,142→ 6,431 total
  • Award
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2014-02-12+7,340→ 7,340 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2014-02-08+2,705→ 10,778 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2014-02-08−2,705→ 5,414 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2014-02-08$315.54/sh−1,276→ 9,502 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2014-02-01+5,159→ 10,044 total
  • Tax Payment
    BIOGEN INC.$BIIB

    Common Stock

    2014-02-01$312.64/sh−1,971→ 8,073 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2014-02-01−5,159→ 5,157 total
  • Sale
    BIOGEN INC.$BIIB

    Common Stock

    2013-09-17$238.98/sh−3,501→ 4,885 total
  • Award
    BIOGEN INC.$BIIB

    Restricted Stock Unit

    2013-02-12+8,573→ 8,573 total

Companies

4

Recent Filings

8

Address

C/O INFINITY PHARMACEUTICALS, INC. 780 MEMORIAL DRIVE

CAMBRIDGE, MA, 02139

View on SEC.gov